Insider transactions

EDGAR

ETON PHARMACEUTICALS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
36 transactions, 766,536 shares
Sum of shares × price per share: 35,006,220.3274

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 114

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-10 Filed 2026-11-12Erdogan-Trinkaus Ipek Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)3,50015.47
54,145

Derived: shares × price per share. Exact value 54145.00.

7,581Direct (D) No— Open filing 0001437749-26-036605 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12Erdogan-Trinkaus Ipek Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,34067.1787
157,198.158

Derived: shares × price per share. Exact value 157198.1580.

5,241Direct (D) No
F2, F3
  • F2 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F3 The shares were sold in multiple trades at prices ranging from $66.645 to $67.62. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-036605 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12Erdogan-Trinkaus Ipek Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,16067.8785
78,739.06

Derived: shares × price per share. Exact value 78739.0600.

4,081Direct (D) No
F2, F4
  • F2 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F4 The shares were sold in multiple trades at prices ranging from $67.6825 to $68.075. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-036605 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12Erdogan-Trinkaus Ipek Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option — underlying Common Stock (3,500) — exercise price 15.47
Disposed (D)3,5000—37,155Direct (D) No
F1
  • F1 The shares subject to the option vest in 48 equal monthly installments from the date of grant (1-12-2026) until fully vested and exercisable on January 12, 2030.
Open filing 0001437749-26-036605 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)12,5007.31
91,375

Derived: shares × price per share. Exact value 91375.00.

12,500Direct (D) No— Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)27,4003.58
98,092

Derived: shares × price per share. Exact value 98092.00.

39,900Direct (D) No— Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)19,6558.61
169,229.55

Derived: shares × price per share. Exact value 169229.55.

59,555Direct (D) No— Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)21,0003.78
79,380

Derived: shares × price per share. Exact value 79380.00.

80,555Direct (D) No— Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,38064.3287
410,417.106

Derived: shares × price per share. Exact value 410417.1060.

74,175Direct (D) No
F5, F6
  • F5 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F6 The shares were sold in multiple trades at prices ranging from $63.755 to $64.685. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,71565.3249
961,255.9035

Derived: shares × price per share. Exact value 961255.9035.

59,460Direct (D) No
F5, F7
  • F5 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F7 The shares were sold in multiple trades at prices ranging from $64.76 to $65.74. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22,60166.2615
1,497,576.1615

Derived: shares × price per share. Exact value 1497576.1615.

36,859Direct (D) No
F5, F8
  • F5 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F8 The shares were sold in multiple trades at prices ranging from $65.76 to $66.75. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)33,95667.1103
2,278,797.3468

Derived: shares × price per share. Exact value 2278797.3468.

2,903Direct (D) No
F5, F9
  • F5 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F9 The shares were sold in multiple trades at prices ranging from $66.76 to $67.61. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,90367.8695
197,025.1585

Derived: shares × price per share. Exact value 197025.1585.

0Direct (D) No
F5, F10
  • F5 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F10 The shares were sold in multiple trades at prices ranging from $67.76 to $67.975. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option — underlying Common Stock (12,500) — exercise price 7.31
Disposed (D)12,5000—0Direct (D) No
F1
  • F1 The shares subject to the option vested on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option — underlying Common Stock (27,400) — exercise price 3.58
Disposed (D)27,4000—0Direct (D) No
F2
  • F2 The shares subject to the option vested on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option — underlying Common Stock (19,655) — exercise price 8.61
Disposed (D)19,6550—0Direct (D) No
F3
  • F3 The shares subject to the option vested on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on May 3, 2022.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-10CASAMENTO CHARLES J Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option — underlying Common Stock (21,000) — exercise price 3.78
Disposed (D)21,0000—29,000Direct (D) No
F4
  • F4 The shares subject to the option vested on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 7, 2023.
Open filing 0001437749-26-036250 Read from the filing’s XML Dispute this row
2026-10-06 Filed 2026-10-06Krempa David Officer: Chief Business Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,16655.0663
229,406.2058

Derived: shares × price per share. Exact value 229406.2058.

43,381Direct (D) No
F1, F2
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F2 The shares were sold in multiple trades at prices ranging from $54.915 to $55.135. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-032240 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-06Krempa David Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)10,522——47,547Direct (D) No
F3
  • F3 On October 2, 2024, the reporting person was granted 42,088 restricted stock units which vest in four equal annual installments beginning October 2, 2025.
Open filing 0001437749-26-032240 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-06Krempa David Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (10,522) — exercise price 0
Disposed (D)10,5220—21,044Direct (D) No
F3
  • F3 On October 2, 2024, the reporting person was granted 42,088 restricted stock units which vest in four equal annual installments beginning October 2, 2025.
Open filing 0001437749-26-032240 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31MAIER PAUL V Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)50,0003.78
189,000

Derived: shares × price per share. Exact value 189000.00.

109,745Direct (D) No— Open filing 0001437749-26-029308 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31MAIER PAUL V Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)36,38758.64
2,133,733.68

Derived: shares × price per share. Exact value 2133733.68.

73,358Direct (D) No
F1, F2
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F2 The shares were sold in multiple trades at prices ranging from $58.50 to $58.97. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-029308 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31MAIER PAUL V Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)13,48560.21
811,931.85

Derived: shares × price per share. Exact value 811931.85.

59,873Direct (D) No
F1, F4
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F4 The shares were sold in multiple trades at prices ranging from $60.00 to $61.00. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-029308 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31MAIER PAUL V Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)12861.77
7,906.56

Derived: shares × price per share. Exact value 7906.56.

59,745Direct (D) No
F1, F5
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F5 The shares were sold in multiple trades at prices ranging from $61.10 to $61.98. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-029308 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31MAIER PAUL V Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)12,5007.31
91,375

Derived: shares × price per share. Exact value 91375.00.

72,245Direct (D) No— Open filing 0001437749-26-029308 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31MAIER PAUL V Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option — underlying Common Stock (50,000) — exercise price 3.78
Disposed (D)50,0000—0Direct (D) No
F3
  • F3 The shares subject to the option vested in 48 equal monthly installments from the date of grant (2-07-2022) until fully vested.
Open filing 0001437749-26-029308 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-31MAIER PAUL V Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option — underlying Common Stock (12,500) — exercise price 7.31
Acquired (A)12,5000—0Direct (D) No
F6
  • F6 The shares subject to the option vested in four equal quarterly installments from the date of grant (02-20-2019) until fully vested.
Open filing 0001437749-26-029308 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28MAIER PAUL V Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)50,0003.78
189,000

Derived: shares × price per share. Exact value 189000.00.

109,745Direct (D) No— Open filing 0001437749-26-029196 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28MAIER PAUL V Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)36,38758.64
2,133,733.68

Derived: shares × price per share. Exact value 2133733.68.

73,358Direct (D) No
F1, F2
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F2 The shares were sold in multiple trades at prices ranging from $58.50 to $58.97. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-029196 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28MAIER PAUL V Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)13,48560.21
811,931.85

Derived: shares × price per share. Exact value 811931.85.

59,873Direct (D) No
F1, F4
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F4 The shares were sold in multiple trades at prices ranging from $60.00 to $61.00. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-029196 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28MAIER PAUL V Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)12861.77
7,906.56

Derived: shares × price per share. Exact value 7906.56.

59,745Direct (D) No
F1, F5
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F5 The shares were sold in multiple trades at prices ranging from $61.10 to $61.98. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-029196 Read from the filing’s XML Dispute this row
2026-08-28 Filed 2026-08-28MAIER PAUL V Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option — underlying Common Stock (50,000) — exercise price 3.78
Disposed (D)50,0000—0Direct (D) No
F3
  • F3 The shares subject to the option vested in 48 equal monthly installments from the date of grant (2-07-2022) until fully vested.
Open filing 0001437749-26-029196 Read from the filing’s XML Dispute this row
2026-08-24 Filed 2026-08-24Krempa David Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,0007.31
182,750

Derived: shares × price per share. Exact value 182750.00.

62,025Direct (D) No— Open filing 0001437749-26-028846 Read from the filing’s XML Dispute this row
2026-08-24 Filed 2026-08-24Krempa David Officer: Chief Business Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,00065.07
1,626,750

Derived: shares × price per share. Exact value 1626750.00.

37,025Direct (D) No
F1, F2
  • F1 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • F2 The shares were sold in multiple trades at prices ranging from $64.88 to $65.57. The price reported above reflects the weighted average sales price.
Open filing 0001437749-26-028846 Read from the filing’s XML Dispute this row
2026-08-24 Filed 2026-08-24Krempa David Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option — underlying Common Stock (25,000) — exercise price 7.31
Disposed (D)25,0000—70,000Direct (D) No
F3
  • F3 The shares subject to the option vested in 48 equal monthly installments from the date of grant (2-20-2019) until fully vested.
Open filing 0001437749-26-028846 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-20BRYNJELSEN SEAN Director · Officer: President CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)47,30760.17
2,846,462.19

Derived: shares × price per share. Exact value 2846462.19.

1,004,909Direct (D) No
F2, F3
  • F2 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • F3 The shares were sold in multiple trades at prices ranging from $59.59 to $60.59. The price above reflects the weighted average sales price.
Open filing 0001437749-26-028651 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-20BRYNJELSEN SEAN Director · Officer: President CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)36,37361.11
2,222,754.03

Derived: shares × price per share. Exact value 2222754.03.

968,536Direct (D) No
F2, F4
  • F2 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • F4 The shares were sold in multiple trades at prices ranging from $60.61 to $61.61. The price above reflects the weighted average sales price.
Open filing 0001437749-26-028651 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-20BRYNJELSEN SEAN Director · Officer: President CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,34262.12
456,085.04

Derived: shares × price per share. Exact value 456085.04.

961,194Direct (D) No
F2, F5
  • F2 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • F5 The shares were sold in multiple trades at prices ranging from $61.63 to $62.52. The price above reflects the weighted average sales price.
Open filing 0001437749-26-028651 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-20BRYNJELSEN SEAN Director · Officer: President CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,97862.65
562,471.7

Derived: shares × price per share. Exact value 562471.70.

1,052,216Direct (D) No
F1, F2
  • F1 The shares were sold in multiple trades at prices ranging from $62.50 to $63.41. The price above reflects the weighted average sales price.
  • F2 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Open filing 0001437749-26-028651 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Krempa David Officer: Chief Business Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (128,985)
Acquired (A)128,9850—128,985Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025706 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04RIEDEL NORBERT G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (10,000)
Acquired (A)10,0000—10,000Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025696 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Erdogan-Trinkaus Ipek Officer: Chief Commercial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (80,000)
Acquired (A)80,0000—80,000Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 80,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025712 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04CASAMENTO CHARLES J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (10,000)
Acquired (A)10,0000—10,000Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025725 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Matthews Judith M. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (32,246)
Acquired (A)32,2460—32,246Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 32,246 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025715 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04Adams Jennifer McKie Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (10,000)
Acquired (A)10,0000—10,000Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025694 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04MAIER PAUL V Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (10,000)
Acquired (A)10,0000—10,000Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025700 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-04BRYNJELSEN SEAN Director · Officer: President CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Common Stock — underlying Common Stock (128,985)
Acquired (A)128,9850—128,985Direct (D) No
F1
  • F1 On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Open filing 0001437749-26-025709 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-17Opaleye Management Inc. 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.001 per share
Disposed (D)15,00037.5431
563,146.5

Derived: shares × price per share. Exact value 563146.5000.

2,665,000Indirect (I) By Opaleye, L.P.No
F3, F1, F4
  • F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.0152 to $37.9148 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
  • F1 Represents securities owned directly by Opaleye, L.P. (the Fund). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund.
  • F4 Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Open filing 0001493152-26-033818 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-17Opaleye Management Inc. 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.001 per share
Disposed (D)13,31537.5431
499,886.3765

Derived: shares × price per share. Exact value 499886.3765.

40,000Indirect (I) By Managed AccountNo
F3, F2, F4
  • F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.0152 to $37.9148 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
  • F2 Securities owned by a separately managed account (the Managed Account). As the portfolio manager of the Managed Account, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.
  • F4 Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Open filing 0001493152-26-033818 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-16Opaleye Management Inc. 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.001 per share
Disposed (D)15,00037.5431
563,146.5

Derived: shares × price per share. Exact value 563146.5000.

2,665,000Indirect (I) By Opaleye, L.P.No
F3, F1, F4
  • F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.0152 to $37.9148 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
  • F1 Represents securities owned directly by Opaleye, L.P. (the Fund). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund.
  • F4 Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Open filing 0001493152-26-033577 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
EcoR1 Capital, LLC Common Stock8.62,470,92009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0000935836-26-000586 Dispute this row
Oleg Nodelman Common Stock8.62,470,92009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0000935836-26-000586 Dispute this row
EcoR1 Capital Fund Qualified, L.P. Common Stock7.92,286,88309/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0000935836-26-000586 Dispute this row
Opaleye Management Inc. Common Stock, par value $0.001 per share8.542,440,000.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 8Open filing 0001493152-26-050455 Dispute this row
Opaleye, L.P. Common Stock, par value $0.001 per share8.472,420,000.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 8Open filing 0001493152-26-050455 Dispute this row
Silverman James Common Stock, par value $0.001 per share8.542,440,000.0009/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 8Open filing 0001493152-26-050455 Dispute this row
BlackRock, Inc. Common Stock6.91,882,41006/30/2026 Filed 2026-07-28SCHEDULE 13G/AAmendment 1Open filing 0002012383-26-002487 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-001214 Dispute this row
The Vanguard Group Common Stock5.011,344,11509/30/2025 Filed 2025-10-30SCHEDULE 13GOpen filing 0000102909-25-000162 Dispute this row
BlackRock, Inc. Common Stock5.71,530,35706/30/2025 Filed 2025-07-17SCHEDULE 13GOpen filing 0002052113-25-003035 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,708,462 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015124,844
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to ETON PHARMACEUTICALS, INC.